Organization: Health Canada
Year: 2023
Month: March
Request Number: A-2017-000107
Request Summary: The New Drug Submission, Supplemental New Drug Submission or similar submission from the drug company to obtain approval for using Anafranil / Altius Clomipramine in the treatment of Obsessive Compulsive Disorder. The medical review of that aforementioned submission performed by Health Canada or by someone contracted by Health Canada.
Disposition: Disclosed in part
Number of pages: 132